MRSA: the first half centuryMOELLERING, Robert C.Journal of antimicrobial chemotherapy (Print). 2012, Vol 67, Num 1, pp 4-11, issn 0305-7453, 8 p.Article

The clinical significance of drug-resistant Streptococcus pneumoniae for the treatment of community-acquired pneumoniaMOELLERING, Robert C.Clinical infectious diseases. 2002, Vol 34, issn 1058-4838, 48 p., SUP1Serial Issue

New approaches to developing antimicrobials for resistant bacteriaMOELLERING, Robert C.Journal of infection and chemotherapy. 2003, Vol 9, Num 1, pp 8-11, issn 1341-321X, 4 p.Article

Moxifloxacin: an assessment after 5 years of clinical useMOELLERING, Robert C.Clinical infectious diseases. 2005, Vol 41, issn 1058-4838, 77 p., SUP2Serial Issue

Discovering new antimicrobial agentsMOELLERING, Robert C.International journal of antimicrobial agents (Print). 2011, Vol 37, Num 1, pp 2-9, issn 0924-8579, 8 p.Article

New Treatments for Multiply Drug-Resistant Gram-Positive BacteriaMOELLERING, Robert C.The Journal of infection. 2009, Vol 59, issn 0163-4453, 82 p., SUP1Serial Issue

A 39-Year-Old Man With a Skin InfectionMOELLERING, Robert C.JAMA, the journal of the American Medical Association. 2008, Vol 299, Num 1, pp 79-87, issn 0098-7484, 9 p.Article

Current Treatment Options for Community-Acquired Methicillin-Resistant Staphylococcus aureus InfectionMOELLERING, Robert C.Clinical infectious diseases. 2008, Vol 46, Num 7, pp 1032-1037, issn 1058-4838, 6 p.Article

Tedizolid - A Novel Oxazolidinone for Gram-Positive InfectionsMOELLERING, Robert C.Clinical infectious diseases. 2014, Vol 58, issn 1058-4838, 59 p., SUP1Serial Issue

Predicting and Defining Vancomycin EfficacyMOELLERING, Robert C.Clinical infectious diseases. 2006, Vol 42, issn 1058-4838, 59 p., SUP1Serial Issue

Respiratory tract infections: resistance trends and treatment optionsMOELLERING, Robert C.Clinical infectious diseases. 2004, Vol 38, issn 1058-4838, 56 p., SUP4Serial Issue

Linezolid: The first oxazolidinone antimicrobialMOELLERING, Robert C.Annals of internal medicine. 2003, Vol 138, Num 2, pp 135-142, issn 0003-4819, 8 p.Article

Tissue-directed antibiotic therapy, February 21-24, 1991 in Phoenix AZMOELLERING, ROBERT C.The American journal of medicine. 1991, Vol 91, Num 3A, issn 0002-9343, 47 p.Conference Proceedings

Clinical implications of pharmacokinetics and pharmacodynamics of fluoroquinolonesWISPELWEY, Brian.Clinical infectious diseases. 2005, Vol 41, pp S127-S135, issn 1058-4838, SUP2Article

Microbial Resistance: Bacteria and MoreMOELLERING, Robert C; WOOD, Martin.Clinical infectious diseases. 2003, Vol 36, issn 1058-4838, 52 p., SUP1Serial Issue

Vancomycin resistance in gram-positive coeiCOURVALIN, Patrice.Clinical infectious diseases. 2006, Vol 42, issn 1058-4838, S25-S34, SUP1Article

Moxifloxacin for the treatment of acute exacerbations of chronic obstructive pulmonary diseaseSETHI, Sanjay.Clinical infectious diseases. 2005, Vol 41, pp S177-S185, issn 1058-4838, SUP2Article

Health economic issues in the treatment of drug-resistant serious Gram-positive infectionsNATHWANI, Dilip.The Journal of infection. 2009, Vol 59, issn 0163-4453, S40-S50, SUP1Article

Treatment of pediatric Gram-positive multidrug-resistant infectionsBLUMER, Jeffrey.The Journal of infection. 2009, Vol 59, issn 0163-4453, S51-S58, SUP1Article

Antimicrobial Resistance Prevention Initiative: proceedings of an expert panel on resistanceMOELLERING, Robert C; FISHMAN, Neil.American journal of infection control. 2006, Vol 34, Num 5, issn 0196-6553, 85 p., SUP1Conference Proceedings

Bacterial Resistance: Laboratory Explanations and Clinical ConsequencesMOELLERING, Robert C; PHILLIPS, Ian.Clinical infectious diseases. 1998, Vol 27, issn 1058-4838, 145 p., SUP1Conference Proceedings

Clinical toleration and safety of azithromycinHOPKINS, S.The American journal of medicine. 1991, Vol 91, Num 3A, pp 3A.40S-3A.45S, issn 0002-9343Conference Paper

Multicenter evaluation of azithromycin and cefaclor in acute lower respiratory tract infectionsDARK, D.The American journal of medicine. 1991, Vol 91, Num 3A, pp 3A.31S-3A.35S, issn 0002-9343Conference Paper

Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapySAKOULAS, George; MOELLERING, Robert C; ELIOPOULOS, George M et al.Clinical infectious diseases. 2006, Vol 42, issn 1058-4838, S40-S50, SUP1Article

Oritavancin: A New Opportunity for Outpatient Therapy of Serious InfectionsTICE, Alan.Clinical infectious diseases. 2012, Vol 54, issn 1058-4838, S239-S243, SUP3Article